Skip to Main Content

Course Objectives

Angiogenesis, Exudation, and Degeneration 2022 – Virtual Edition

Course Objectives

Upon completion of this course, participants should be able to:

  • Examine new evidence for the pathophysiology, detection, prediction of progression, and treatments of dry age-related macular degeneration
  • Evaluate the clinical use of available anti-VEGF drugs for exudative ocular diseases 
  • Apply the next generation of anti-VEGF therapies that were used in clinical trials and which have recently been approved
  • Evaluate alternative therapies that could help patients in their clinical practice, especially the use of complement inhibitors for the treatment of non-exudative age-related macular degeneration in which diagnosis of high-risk eyes will be the most important criteria for treatment
  • Evaluate the benefits and limitations of OCT angiography and how this technology might improve the diagnosis and classification of macular and retinal diseases, as well as the clinical management of patients with these diseases
  • Incorporate the latest advances of artificial intelligence, specifically machine learning,  in the diagnosis and treatment of retinal disease in their clinical practice